NCT05394116: A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
- State
- Under way
- Phase
- Phase 3
- People
- 63 taking part
- Started
- 21 Nov 2022
- Primary completion
- 17 Jul 2025
- Arms
- Placebo
- Results
- Posted on the registry
- Papers
- doi:10.1016/s0140-6736(26)01599-0
- 27 May 2022: Trial registered
- 21 Nov 2022: Trial started
- 17 Nov 2026: Trial results posted